Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine vs Bupropion for Suicidality in MDD and Alcoholism
NCT00449007Phase 4Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Feb 2006
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluoxetine in major depressive disorder (MDD), alcohol use disorder (AUD), Suicidal Behavior (SB), sponsored by New York State Psychiatric Institute. Started Feb 2006; status: terminated.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)alcohol use disorder (AUD)Suicidal Behavior (SB)
Beyond the preview
Go deeper on NCT00449007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449007.